News for Quidel Corporation (QDEL)

QuidelOrtho Corporation (Nasdaq: QDEL) (the ”œCompany” or ”œQuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for

**media[528155]**

QuidelOrtho reports Q4 revenue in line with guidance

The U.S. Legionella Testing Market Size sector reached a market value of USD 103.6 million in 2022. Future projections show a bright outlook, with a Compound Annual Growth Rate (CAGR) of 9.2% from…

The U.S. Point of Care Diagnostics Market Size sector reached a market value of USD 9.45 billion in 2023. Future projections show a bright outlook, with a Compound Annual Growth Rate (CAGR) of 6.9%…

The COVID-19 Diagnostics Market Size sector reached a market value of USD 46.76 Billion in 2021. Future projections show a bright outlook, with a Compound Annual Growth Rate (CAGR) of -13.1% from…

QuidelOrtho announces executive leadership changes

Quidel (QDEL) earnings results for Q3 are anticipated on Nov 7, with consensus estimates of $0.32 EPS and $643.52M revenue.

Global Fertility Testing Devices Market Size Was Valued at USD 702.59 Million In 2023 And Is Projected to Reach USD 1171.55 Million By 2032, Growing at A...

Influenza Diagnostics Market will reach a value of USD 1.46 Billion by 2031, with a CAGR of 3.5% during the forecast period (2024-2031)....

Difficulties in Trichomoniasis Detection and Treatment Driving Need for Proactive Measures through Adoption of Trichomonas Rapid Testing Kits....

Advancements and Projections in the Global Bacterial and Viral Specimen Collection Market: Insights, Trends, Opportunities, and Recent Developments...

As per Fortune Business Insights’ report, the cardiac troponin market share sector attained a worth of USD 3.01 billion in 2023. Forecasts indicate a promising path, foreseeing a Compound Annual…

The fertility testing devices market is driven by rising infertility rates, increasing awareness of reproductive health, advancements in technology, and...

The Global Physician Office Diagnostic Market Size was Valued at USD 101.25 Billion in 2023 and the Worldwide Physician Office Diagnostic Market Size is...

Investments Increasing to Improve Design, Durability, and Quality of Rapid Influenza Diagnostic Test Kits...

The norovirus diagnostics market was valued at USD 65.5 Billion in 2023 and is expected to reach USD 130.4 Billion by 2032 at a CAGR of 7.9%....

Increasing need for rapid test results and point of care diagnostic...

The global influenza diagnostics market size and share are currently valued at USD 0.79 billion in 2023. It is anticipated to generate an estimated revenue...